Free Trial

Ascendant Resources (ASND) Competitors

Ascendant Resources logo
C$0.08 -0.01 (-6.25%)
As of 05/21/2025 10:24 AM Eastern

ASND vs. HEXO, VIR, ZOM, BRM, RGC, AEZS, ACST, NEPT, DBV, and GRI

Should you be buying Ascendant Resources stock or one of its competitors? The main competitors of Ascendant Resources include HEXO (HEXO), Viridium Pacific Group (VIR), Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM), BioRem (BRM), Relevant Gold (RGC), Aeterna Zentaris (AEZS), Acasti Pharma (ACST), Neptune Wellness Solutions (NEPT), Doubleview Capital (DBV), and Galore Resources (GRI). These companies are all part of the "pharmaceutical products" industry.

Ascendant Resources vs.

HEXO (TSE:HEXO) and Ascendant Resources (TSE:ASND) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, media sentiment, profitability, risk, institutional ownership, community ranking and valuation.

Ascendant Resources has lower revenue, but higher earnings than HEXO. Ascendant Resources is trading at a lower price-to-earnings ratio than HEXO, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HEXOC$124.10M0.00-C$273.18M-C$3.41N/A
Ascendant ResourcesN/AN/A-C$19.42M-C$0.21-0.35

7.6% of HEXO shares are held by institutional investors. Comparatively, 14.5% of Ascendant Resources shares are held by institutional investors. 3.0% of HEXO shares are held by company insiders. Comparatively, 3.3% of Ascendant Resources shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

HEXO has a beta of 2.13, suggesting that its share price is 113% more volatile than the S&P 500. Comparatively, Ascendant Resources has a beta of 1.57, suggesting that its share price is 57% more volatile than the S&P 500.

In the previous week, HEXO's average media sentiment score of 0.00 equaled Ascendant Resources'average media sentiment score.

Company Overall Sentiment
HEXO Neutral
Ascendant Resources Neutral

Ascendant Resources received 37 more outperform votes than HEXO when rated by MarketBeat users. Likewise, 62.67% of users gave Ascendant Resources an outperform vote while only 47.90% of users gave HEXO an outperform vote.

CompanyUnderperformOutperform
HEXOOutperform Votes
57
47.90%
Underperform Votes
62
52.10%
Ascendant ResourcesOutperform Votes
94
62.67%
Underperform Votes
56
37.33%

Ascendant Resources has a net margin of 0.00% compared to HEXO's net margin of -220.13%. Ascendant Resources' return on equity of 144.18% beat HEXO's return on equity.

Company Net Margins Return on Equity Return on Assets
HEXO-220.13% -106.39% -14.96%
Ascendant Resources N/A 144.18%-12.94%

Summary

Ascendant Resources beats HEXO on 9 of the 12 factors compared between the two stocks.

Get Ascendant Resources News Delivered to You Automatically

Sign up to receive the latest news and ratings for ASND and its competitors with MarketBeat's FREE daily newsletter.

ASND vs. The Competition

MetricAscendant ResourcesOther Industrial Metals & Mining IndustryMaterials SectorTSE Exchange
Market CapC$9.73MC$1.05BC$3.08BC$5.94B
Dividend Yield4.75%6.19%5.20%6.32%
P/E Ratio-0.3538.9867.8829.92
Price / SalesN/A19,454.1525,591,212,775,269,400.00823.31
Price / Cash160.0025.1624.3483.71
Price / Book-0.786.815.213.99
Net Income-C$19.42MC$70.70MC$156.48MC$301.32M
7 Day PerformanceN/A1.49%2.45%0.86%
1 Month PerformanceN/A6.97%5.51%7.58%
1 Year PerformanceN/A46.37%16.98%16.12%

Ascendant Resources Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ASND
Ascendant Resources
0.4397 of 5 stars
C$0.08
-6.3%
C$0.30
+300.0%
+25.0%C$9.73MN/A-0.35640Gap Down
HEXO
HEXO
N/AN/AN/AN/AC$38.72MC$124.10M-0.26690
VIR
Viridium Pacific Group
N/AC$0.38
+5.6%
N/A+0.0%C$37.52MC$1.09M-2.97580Gap Up
ZOM
Zomedica Pharmaceuticals Corp. (ZOM.V)
N/AC$0.29
-6.6%
N/A+0.0%C$36.73MN/A-2.6150Gap Down
BRM
BioRem
N/AC$2.10
-3.7%
N/A+6.2%C$34.44MC$41.84M6.4934,300Gap Up
RGC
Relevant Gold
N/AC$0.36
+9.1%
N/A+22.6%C$26.88MN/A-5.1410Gap Up
AEZS
Aeterna Zentaris
N/AN/AN/AN/AC$25.37MC$2.37M-2.6120
ACST
Acasti Pharma
N/AC$0.58
+1.8%
N/A+0.0%C$18.19MC$2.71M-1.2132
NEPT
Neptune Wellness Solutions
N/AN/AN/AN/AC$15.73MC$48.80M-0.08130Gap Down
DBV
Doubleview Capital
N/AC$0.08
+7.1%
N/A+0.0%C$8.62MN/A-37.5080Gap Up
GRI
Galore Resources
N/AC$0.04
+33.3%
N/A+200.0%C$7.09MN/A-4.001

Related Companies and Tools


This page (TSE:ASND) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners